Glazer Capital LLC’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Glazer Capital LLC’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$85K	Buy
2022 Q2	$56K	Buy
2022 Q1	$30K	Buy
2021 Q4	–	Sell
2021 Q3	$791K	Hold
2021 Q2	$814K	Sell
2021 Q1	$829K	Sell
2020 Q4	$2.41M	Buy